Bionexus Gene Lab Stock Forecast

Sell candidate since Jun 05, 2026

The BioNexus Gene Lab Corporation stock price fell by -4.14% on the last day (Friday, 5th Jun 2026) from $2.30 to $2.20. During the last trading day the stock fluctuated 2.80% from a day low at $2.14 to a day high of $2.20. The price has been going up and down for this period, and there has been a 8.91% gain for the last 2 weeks. Volume has increased on the last day by 4 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 5 thousand shares were bought and sold for approximately $11.45 thousand.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -11.17% during the next 3 months and, with a 90% probability hold a price between $1.69 and $2.11 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

BGLC Signals & Forecast

The BioNexus Gene Lab Corporation stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $2.29. On a fall, the stock will find some support from the long-term average at approximately $2.14. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, May 28, 2026, and so far it has fallen -8.33%. Further fall is indicated until a new bottom pivot has been found. BioNexus Gene Lab Corporation gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for BioNexus Gene Lab Corporation stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.07 and $2.06. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, BioNexus Gene Lab Corporation finds support just below today's level at $2.07. If this is broken, then the next support from accumulated volume will be at $2.06 and $1.98.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0600 between high and low, or 2.80%. For the last week, the stock has had daily average volatility of 6.83%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BGLC) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect BioNexus Gene Lab Corporation to open at $2.18, and during the day (based on 14 day Average True Range), to move between $2.13 and $2.27, which gives a possible trading interval of +/-$0.138 (+/-6.49%) up or down from last closing price. If BioNexus Gene Lab Corporation takes out the full calculated possible swing range there will be an estimated 6.49% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.22 (0.91%) than the support at $2.07 (5.91%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is BioNexus Gene Lab Corporation stock A Buy?

BioNexus Gene Lab Corporation holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -1.516 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $2.18 ( 0.91%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk